TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 307 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $792,853 | +134.6% | 48,110 | +94.3% | 0.00% | +200.0% |
| Q4 2021 | $338,000 | +51.6% | 24,763 | +86.5% | 0.00% | 0.0% |
| Q2 2021 | $223,000 | -32.2% | 13,276 | -26.4% | 0.00% | -50.0% |
| Q1 2021 | $329,000 | -50.7% | 18,029 | -51.8% | 0.00% | -77.8% |
| Q3 2020 | $668,000 | +157.9% | 37,434 | +184.7% | 0.01% | +350.0% |
| Q4 2019 | $259,000 | +12.6% | 13,148 | +16.5% | 0.00% | 0.0% |
| Q1 2019 | $230,000 | – | 11,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |